Expression of CCR5 or CCL5 is broadly linked to poor prognosis in cancer, due in part to the promotion of MDSCs, plus genetic and metabolic alterations to antitumor immune cells and cancer cells, angiogenesis, and ECM remodeling [123]. The gene discussed is CCL5; the disease is cancer.